← Back to Clinical Trials
Recruiting NCT05734287

NCT05734287 The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05734287
Status Recruiting
Phase
Sponsor Woman's Health University Hospital, Egypt
Condition PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Study Type OBSERVATIONAL
Enrollment 260 participants
Start Date 2024-06-28
Primary Completion 2025-07-15

Eligibility & Interventions

Sex Female only
Min Age 15 Years
Max Age 35 Years
Study Type OBSERVATIONAL
Interventions
clinical, biophysical and biochemical assessment of young females with clinical hyperandrogenism

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 260 participants in total. It began in 2024-06-28 with a primary completion date of 2025-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This mixed cohort study will test the frequency of PCOS among young females presenting with one of the clinical hyperandrogenism criteria: acne, hirsutism and/or hair loss. Diagnosis will be based on the recent PCOS clinical, biochemical and biophysical criteria recently published " International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2018".

Eligibility Criteria

Inclusion Criteria: * Clinical hyperandrogenism Exclusion Criteria: * Age less than 15 or more than 35 years.

Frequently Asked Questions

Who can join the NCT05734287 clinical trial?

This trial is open to female participants only, aged 15 Years or older, up to 35 Years, studying PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05734287 currently recruiting?

Yes, NCT05734287 is actively recruiting participants. Visit ClinicalTrials.gov or contact Woman's Health University Hospital, Egypt to inquire about joining.

Where is the NCT05734287 trial being conducted?

This trial is being conducted at Doha, Qatar.

Who is sponsoring the NCT05734287 clinical trial?

NCT05734287 is sponsored by Woman's Health University Hospital, Egypt. The trial plans to enroll 260 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology